Cavallaro U, Christofori G
Research Institute of Molecular Pathology, Vienna, Austria.
J Neurooncol. 2000 Oct-Nov;50(1-2):63-70. doi: 10.1023/a:1006414621286.
The formation of new blood vessels (angiogenesis) is crucial for the growth and persistence of primary solid tumors and their metastases. Furthermore, angiogenesis is also required for metastatic dissemination, since an increase in vascular density will allow easier access of tumor cells to the circulation. Induction of angiogenesis precedes the formation of malignant tumors, and increased vascularization seems to correlate with the invasive properties of tumors and thus with the malignant tumor phenotype. In the last few years, the discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. However, although angiogenesis appears to be a rate-limiting event in tumor growth and metastatic dissemination, a direct connection between the induction of angiogenesis and the progression to tumor malignancy is less well understood. In this review, we discuss the most recent observations concerning the modulation of angiogenesis and their implications in tumor progression, as well as their potential impact on cancer therapy.
新血管形成(血管生成)对于原发性实体瘤及其转移灶的生长和持续存在至关重要。此外,血管生成对于转移扩散也是必需的,因为血管密度增加会使肿瘤细胞更容易进入循环系统。血管生成的诱导先于恶性肿瘤的形成,血管化增加似乎与肿瘤的侵袭特性相关,因此也与恶性肿瘤表型相关。在过去几年中,肿瘤源性血管生成调节剂的发现和特性研究极大地促进了我们对肿瘤如何调节血管生成的理解。然而,尽管血管生成似乎是肿瘤生长和转移扩散中的一个限速事件,但血管生成诱导与肿瘤恶性进展之间的直接联系仍不太清楚。在这篇综述中,我们讨论了有关血管生成调节的最新观察结果及其对肿瘤进展的影响,以及它们对癌症治疗的潜在影响。